Skip to content

News

Calculus sponsors FT Triathlon – Human Race

We are proud to announce that we are sponsoring the FT Triathlon run by Human Race, which takes place on Saturday 13th September at Dorney Lake, Windsor. The Financial Times Triathlon is in support of Impetus – The Private Equity Foundation. Calculus are entering a team and will be sponsoring the goody bags given out … Continued

Calculus Capital invests in Arcis Biotechnology

Calculus Capital announces today that it has invested £1.25m in Arcis. This investment is part of a larger fundraising of £1.7m and follows previous investments in Arcis totalling £2m made in May 2012 and June 2013. Based in Cheshire, Arcis develops patented compounds and technologies. It then commercialises these novel technologies and application methods to … Continued

Calculus Capital invests in WheelRight

Private equity fund manager Calculus Capital invests £2.5m in WheelRight Ltd, a tyre monitoring company. WheelRight develops and sells advanced remote tyre monitoring equipment, which accurately measures the pressure within a vehicle’s tyres when the vehicle is driven over a sensor plate. This system, which is effective regardless of vehicle or tyre type, provides fleet … Continued

Calculus Capital goes for the double

Calculus Capital has notched up two deals, investing £1.25m in R&D company Arcis and £2.5m in WheelRight, a tyre monitoring company. Arcis develops patented compounds and technologies related to DNA extraction and molecular diagnostics, and pesticides used for agriculture. It then licenses these products to commercial partners. WheelRight, whose client list includes Stagecoach, sells remote … Continued

Calculus Capital invests in Premaitha

Calculus Capital has invested approximately £1m in Premaitha Health. This investment is part of a larger fundraising of £7.25 million and subsequent admission to trading on London Stock Exchange’s junior market for growth companies, AIM via a reverse takeover. Trading in the ordinary shares commenced on July 4th 2014. Premaitha employs next generation DNA analysis … Continued

Calculus Capital invests in Chop’d

Calculus Capital is pleased to announce that it has led a £2 million investment in Chop’d, a salad bar chain with nine sites across London. The deal represents the second investment in the restaurant sector for Calculus, led by Investment Director Rick Jones. The investment will be used to expand the chain from nine to … Continued

Another successful Exit from Calculus

Calculus Capital has successfully exited its investors’ shares in Epistem – a personalised medicine and biotechnology company commercialising its expertise in stem cells, infectious disease diagnostics and pharmacogenomics as a guide to therapy selection. Calculus sold the shares in Epistem in May 2014, through a placing in the market, delivering yet another great return to our investors. … Continued

Important Information

The investments referred to in this website are not suitable for all investors. Calculus Capital Limited is not able to give advice to prospective investors about the suitability of the investments. Prospective investors are recommended to seek specialist tax and financial advice before investing in the Calculus EIS Fund or Calculus VCT.

An investment into the Calculus EIS Fund of Calculus VCT may only be made on the basis of reading in full the information set out in the relevant Information Memorandum or prospectus.

When investing, your capital is at risk. The value of shares and income from them may go down as well as up and despite the tax relief you may not recover the amount originally invested. An investment in smaller and unquoted companies carries a higher risk than many other forms of investment. Shares in unquoted companies are not readily marketable. You should not invest in an EIS or VCT unless you can afford to lose some or all of your capital.

An EIS or VCT investment is only appropriate for investors with a medium to long term investment horizon; the timing and extent of realisation cannot be predicted and may extend beyond five years. It is not possible to allow a partial withdrawal of your investment. You may request a total withdrawal, but since many investments made will be in unquoted companies, this may not be possible. Withdrawal within three years for the EIS and five years for the VCT would lead to repayment of any tax reliefs received.

The tax benefits available depend upon your individual circumstances and these benefits may change dependent upon future legislation.

This site uses cookies as described in our Cookie Policy. By continuing to browse this site you are agreeing to our use of cookies.

I have read and understood this important information

Important Information

The investments referred to in this website are not suitable for all investors. Calculus Capital Limited is not able to give advice to prospective investors about the suitability of the investments. Prospective investors are recommended to seek specialist tax and financial advice before investing in the Calculus EIS Fund or Calculus VCT.

An investment into the Calculus EIS Fund of Calculus VCT may only be made on the basis of reading in full the information set out in the relevant Information Memorandum or prospectus.

When investing, your capital is at risk. The value of shares and income from them may go down as well as up and despite the tax relief you may not recover the amount originally invested. An investment in smaller and unquoted companies carries a higher risk than many other forms of investment. Shares in unquoted companies are not readily marketable. You should not invest in an EIS or VCT unless you can afford to lose some or all of your capital.

An EIS or VCT investment is only appropriate for investors with a medium to long term investment horizon; the timing and extent of realisation cannot be predicted and may extend beyond five years. It is not possible to allow a partial withdrawal of your investment. You may request a total withdrawal, but since many investments made will be in unquoted companies, this may not be possible. Withdrawal within three years for the EIS and five years for the VCT would lead to repayment of any tax reliefs received.

The tax benefits available depend upon your individual circumstances and these benefits may change dependent upon future legislation.

This site uses cookies as described in our Cookie Policy. By continuing to browse this site you are agreeing to our use of cookies.

I have read and understood this important information